← Back to Search

ESP with Bupivacaine Group for Postoperative Pain

Phase 3

Recruiting

Led By Udit Chaddha, MBBS

Research Sponsored by Icahn School of Medicine at Mount Sinai

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at 2 hours post-intervention and 24 hours post-intervention

Awards & highlights

Study Summary

This trial will compare the effectiveness of a pain relief technique called erector spinae plane block with Bupivacaine to reduce pain after a medical procedure called thoracoscopy. The trial will

Who is the study for?

This trial is for individuals undergoing medical thoracoscopy, a procedure to look inside the chest. Participants should be those who need this procedure and are interested in managing postoperative pain. Specific eligibility details aren't provided, but typically participants must meet certain health criteria.Check my eligibility

What is being tested?

The study tests if injecting Bupivacaine near the spine (Erector Spinae Plane Block) reduces pain after chest examinations compared to no injection (placebo). It's a triple-blind study, meaning neither patients, doctors nor assessors know who gets the real treatment or placebo.See study design

What are the potential side effects?

Bupivacaine can cause side effects like numbness and weakness where injected, low blood pressure, nausea or ringing in ears. Placebos generally have no active ingredients so any side effects would likely be psychological.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at 2 hours post-intervention and 24 hours post-intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at 2 hours post-intervention and 24 hours post-intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and at 2 hours post-intervention and 24 hours post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Visual Analog Scale (VAS) for Pain

Secondary outcome measures

Change in the Numerical Rating Scale

Dosage of Analgesic use

Number of Analgesic use

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: ESP with Bupivacaine GroupExperimental Treatment2 Interventions

Erector spinae plane block with bupivacaine.

Group II: ESP with PlaceboPlacebo Group2 Interventions

Erector spinae plane injection with a placebo (normal saline).

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Icahn School of Medicine at Mount SinaiLead Sponsor

862 Previous Clinical Trials

525,558 Total Patients Enrolled

3 Trials studying Postoperative Pain

356 Patients Enrolled for Postoperative Pain

Udit Chaddha, MBBSPrincipal InvestigatorPrincipal Investigator

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current total number of participants being recruited for this clinical study?

"Indeed, the information available on clinicaltrials.gov highlights that this specific medical trial is actively seeking individuals to participate. The study was initially shared with the public on March 13th, 2024 and most recently updated on the same day. A total of 68 patients are sought after from a single designated site for enrollment in this research endeavor."

Answered by AI

What are the potential risks associated with employing ESP along with Bupivacaine in individuals?

"Our team at Power rates the safety of ESP with Bupivacaine Group as a 3 on our scale, considering this trial's Phase 3 status. This classification suggests there is existing evidence supporting effectiveness and multiple data sets confirming safety protocols."

Answered by AI

Is it possible for patients to enroll in this ongoing clinical trial?

"Yes, the details on clinicaltrials.gov reveal that this study is currently in the recruitment phase. The trial was first listed on March 13th, 2024 and last revised on the same date. It aims to enroll a total of 68 participants at a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Erector Spinae Plane Block With Bupivacaine for Medical Thoracoscopy

Udit Chaddha 2024. "Erector Spinae Plane Block With Bupivacaine for Medical Thoracoscopy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06313632.

All > New York City > Philadelphia